<?xml version="1.0" encoding="UTF-8"?>

<article>
<articleinfo>
<bibliomisc>MEDLINE:92135176</bibliomisc>
</articleinfo>
<title>
<sentence><w c="NN">Influence</w> <w c="IN">of</w> <cons lex="estradiol" sem="G#lipid"><w c="NN">estradiol</w></cons> <w c="CC">and</w> <cons lex="tamoxifen" sem="G#other_organic_compound"><w c="NN">tamoxifen</w></cons> <w c="IN">on</w> <w c="NN">susceptibility</w> <w c="IN">of</w> <cons lex="human_breast_cancer_cell_line" sem="G#cell_line"><w c="JJ">human</w> <w c="NN">breast</w> <w c="NN">cancer</w> <w c="NN">cell</w> <w c="NNS">lines</w></cons> <w c="TO">to</w> <w c="NN">lysis</w> <w c="IN">by</w> <cons lex="lymphokine-activated_killer_cell" sem="G#cell_type"><w c="JJ">lymphokine-activated</w> <w c="NN">killer</w> <w c="NNS">cells</w></cons><w c=".">.</w></sentence>
</title>
<abstract>
<sentence><w c="DT">The</w> <w c="NN">design</w> <w c="IN">of</w> <w c="NN">combination</w> <w c="JJ">hormonal</w> <w c="CC">and</w> <cons lex="immunotherapeutic_protocol" sem="G#other_name"><w c="JJ">immunotherapeutic</w> <w c="NNS">protocols</w></cons> <w c="IN">for</w> <cons lex="breast_cancer_patient" sem="G#multi_cell"><w c="NN">breast</w> <w c="NN">cancer</w> <cons lex="patient" sem="G#multi_cell"><w c="NNS">patients</w></cons></cons> <w c="MD">may</w> <w c="VB">be</w> <w c="VBN">facilitated</w> <w c="IN">by</w> <w c="NN">analysis</w> <w c="IN">of</w> <w c="JJ">preclinical</w> <w c="FW">in</w> <cons lex="vitro_model_system" sem="G#other_name"><w c="FW">vitro</w> <w c="JJ">model</w> <w c="NNS">systems</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="Estrogen_receptor_positive_(ER+:_MCF-7)_and_negative_(ER-:_MDA-MB-231)_human_breast_cancer_cell_line" sem="G#cell_line"><w c="NN">Estrogen</w> <w c="NN">receptor</w> <w c="JJ">positive</w> <w c="(">(</w><cons lex="ER+:_MCF-7" sem="G#cell_line"><w c="JJ">ER+</w><w c=":">:</w> <w c="NN">MCF-7</w></cons><w c=")">)</w> <w c="CC">and</w> <w c="JJ">negative</w> <w c="(">(</w><cons lex="ER-:_MDA-MB-231" sem="G#cell_line"><w c="JJ">ER-</w><w c=":">:</w> <w c="NN">MDA-MB-231</w></cons><w c=")">)</w> <cons lex="human_breast_cancer_cell_line" sem="G#cell_line"><w c="JJ">human</w> <w c="NN">breast</w> <w c="NN">cancer</w> <w c="NN">cell</w> <w c="NNS">lines</w></cons></cons> <w c="VBD">were</w> <w c="VBN">utilized</w> <w c="TO">to</w> <w c="VB">evaluate</w> <w c="DT">the</w> <w c="NNS">effects</w> <w c="IN">of</w> <cons lex="tamoxifen" sem="G#other_organic_compound"><w c="NN">tamoxifen</w></cons> <w c="(">(</w><cons lex="TAM" sem="G#other_organic_compound"><w c="NN">TAM</w></cons><w c=")">)</w> <w c="CC">and</w> <cons lex="estradiol" sem="G#lipid"><w c="NN">estradiol</w></cons> <w c="(">(</w><cons lex="E2" sem="G#lipid"><w c="NN">E2</w></cons><w c=")">)</w> <w c="IN">on</w> <w c="NN">modulation</w> <w c="IN">of</w> <cons lex="breast_cancer_target_susceptibility" sem="G#other_name"><w c="NN">breast</w> <w c="NN">cancer</w> <w c="NN">target</w> <w c="NN">susceptibility</w></cons> <w c="TO">to</w> <w c="NN">lysis</w> <w c="IN">by</w> <cons lex="lymphokine-activated_killer_(LAK)_cell" sem="G#cell_type"><w c="JJ">lymphokine-activated</w> <w c="NN">killer</w> <w c="(">(</w><w c="NN">LAK</w><w c=")">)</w> <w c="NNS">cells</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="E2-stimulated_ER+_cell" sem="G#cell_line"><cons lex="E2" sem="G#lipid"><w c="*">E2</w></cons><w c="JJ">-stimulated</w> <w c="JJ">ER+</w> <w c="NNS">cells</w></cons> <w c="VBD">were</w> <w c="RBR">more</w> <w c="JJ">susceptible</w> <w c="TO">to</w> <w c="NN">lysis</w> <w c="IN">by</w> <cons lex="LAK_cell" sem="G#cell_type"><w c="NN">LAK</w> <w c="NNS">cells</w></cons> <w c="IN">than</w> <w c="VBG">corresponding</w> <cons lex="TAM-treated" sem="G#cell_line"><cons lex="TAM" sem="G#other_organic_compound"><w c="*">TAM</w></cons><w c="JJ">-treated</w></cons> <w c="CC">or</w> <cons lex="control_cell" sem="G#cell_type"><w c="NN">control</w> <w c="NNS">cells</w></cons><w c=",">,</w> <w c="IN">while</w> <w c="NN">treatment</w> <w c="IN">of</w> <cons lex="ER-_cell" sem="G#cell_line"><w c="NNS">ER- cells</w></cons> <w c="IN">with</w> <w c="CC">either</w> <cons lex="E2" sem="G#lipid"><w c="NN">E2</w></cons> <w c="CC">or</w> <cons lex="TAM" sem="G#other_organic_compound"><w c="NN">TAM</w></cons> <w c="RB">alone</w> <w c="VBD">did</w> <w c="RB">not</w> <w c="VB">alter</w> <w c="IN">from</w> <w c="NN">control</w> <w c="PRP$">their</w> <w c="NN">susceptibility</w> <w c="TO">to</w> <w c="DT">this</w> <cons lex="immune-mediated_lysis" sem="G#other_name"><w c="JJ">immune-mediated</w> <w c="NN">lysis</w></cons><w c=".">.</w></sentence>
<sentence><w c="DT">All</w> <cons lex="(AND ER+_cell ER-_cell)" sem="(AND G#cell_line G#cell_line)"><cons lex="ER+*"><w c="JJ">ER+</w></cons> <w c="CC">and</w> <cons lex="ER-*"><w c="*">ER-</w></cons> <cons lex="*cell"><w c="NNS">cells</w></cons></cons> <w c="VBN">tested</w> <w c="VBD">remained</w> <w c="JJ">sensitive</w> <w c="IN">after</w> <w c="NN">treatment</w> <w c="IN">with</w> <cons lex="TAM" sem="G#other_organic_compound"><w c="NN">TAM</w></cons> <w c="TO">to</w> <w c="NN">lysis</w> <w c="IN">by</w> <cons lex="LAK_cell" sem="G#cell_type"><w c="NN">LAK</w> <w c="NNS">cells</w></cons><w c=".">.</w></sentence>
<sentence><w c="IN">In</w> <w c="NN">addition</w><w c=",">,</w> <w c="DT">an</w> <cons lex="adenocarcinoma_reactive_human-mouse_chimeric_monoclonal_antibody" sem="G#protein_molecule"><w c="NN">adenocarcinoma</w> <w c="JJ">reactive</w> <w c="JJ">human-mouse</w> <w c="JJ">chimeric</w> <w c="JJ">monoclonal</w> <w c="NN">antibody</w></cons> <w c="(">(</w><cons lex="ING-1" sem="G#protein_molecule"><w c="NN">ING-1</w></cons><w c=")">)</w> <w c="VBD">was</w> <w c="JJ">able</w> <w c="TO">to</w> <w c="RB">significantly</w> <w c="VB">boost</w> <w c="FW">in</w> <cons lex="vivo_generated_LAK_cell-mediated_lysis" sem="G#other_name"><w c="FW">vivo</w> <w c="VBN">generated</w> <w c="NN">LAK</w> <w c="JJ">cell-mediated</w> <w c="NN">lysis</w></cons> <w c="IN">of</w> <cons lex="(AND control_ER+_cell control_ER-_cell E2-treated_ER+_cell E2-treated_ER-_cell TAM-treated_ER+_cell TAM-treated_ER-_cell)" sem="(AND G#cell_line G#cell_line G#cell_line G#cell_line G#cell_line G#cell_line)"><cons lex="control*"><w c="NN">control</w></cons><w c=",">,</w> <cons lex="E2-treated*"><w c="JJ">E2-treated</w></cons><w c=",">,</w> <w c="CC">and</w> <cons lex="TAM-treated*"><w c="JJ">TAM-treated</w></cons> <cons lex="(AND *ER+_cell *ER-_cell)" sem="(AND G#cell_line G#cell_line)"><cons lex="ER+*"><w c="JJ">ER+</w></cons> <w c="CC">and</w> <cons lex="ER-*"><w c="*">ER-</w></cons> <cons lex="*cell"><w c="NNS">cells</w></cons></cons></cons><w c=".">.</w></sentence>
<sentence><w c="DT">These</w> <w c="FW">in</w> <w c="FW">vitro</w> <w c="NNS">results</w> <w c="VBP">provide</w> <w c="DT">a</w> <w c="JJ">preclinical</w> <w c="NN">rationale</w> <w c="IN">for</w> <w c="FW">in</w> <w c="FW">vivo</w> <w c="NN">testing</w> <w c="IN">of</w> <cons lex="TAM" sem="G#other_organic_compound"><w c="NN">TAM</w></cons><w c=",">,</w> <cons lex="interleukin-2" sem="G#protein_molecule"><w c="NN">interleukin-2</w></cons> <w c="(">(</w><cons lex="IL-2" sem="G#protein_molecule"><w c="NN">IL-2</w></cons><w c=")">)</w><w c=",">,</w> <w c="CC">and</w> <cons lex="breast_cancer_reactive_antibody-dependent_cellular_cytotoxicity" sem="G#other_name"><w c="NN">breast</w> <w c="NN">cancer</w> <w c="JJ">reactive</w> <w c="JJ">antibody-dependent</w> <w c="JJ">cellular</w> <w c="NN">cytotoxicity</w></cons> <w c="VBG">facilitating</w> <w c="NN">antibody</w> <w c="IN">in</w> <cons lex="patient" sem="G#multi_cell"><w c="NNS">patients</w></cons> <w c="IN">with</w> <w c="JJ">refractory</w> <w c="CC">or</w> <cons lex="high_risk_breast_cancer" sem="G#other_name"><w c="JJ">high</w> <w c="NN">risk</w> <w c="NN">breast</w> <w c="NN">cancer</w></cons><w c=".">.</w></sentence>
</abstract>
</article>
